ArticleDiscover oncology2025

Co-administration of nobiletin and tetrahydrocurcumin enhanced the cytotoxicity to breast cancer through inhibiting CYP1A1 enzyme: from the perspective of pharmacokinetic interactions.

Hongming Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.